MedPath

Impact of pancreatic parenchymal compression for the prevention of postoperative pancreatic fistula in patients undergoing distal pancreatectomy

Not Applicable
Conditions
C25
Malignant neoplasm of pancreas
Registration Number
DRKS00034392
Lead Sponsor
Klinik für Allgemein- und Viszeralchirurgie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Age = 18 years
- Indication for elective distal pancreatectomy, with or without splenectomy
- Minimally invasive or open surgical removal (resection) for tumors or cysts of the pancreatic tail
- ASA I-III
- Verbal and written informed consent
- Ability to understand the content and scope of the study and to be able to implement it

Exclusion Criteria

- Distal pancreatectomy as a secondary procedure during a gastric or colon
resection
- Participation in another study that influences the study results
- > ASA 3

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of pancreatic fistula.<br>There is a follow-up of 30 days after the operation.
Secondary Outcome Measures
NameTimeMethod
- Postoperative intervention rate <br>- Reoperation rate<br>- OP - specific morbidity (within the hospital stay and 30 days postoperative)<br>- Postoperative complications classified according to the Clavien-Dindo classification<br>- Mortality (within the hospital stay and 30 days postoperatively)<br>- Length of stay IMC/ICU<br>- Length of hospital of stay
© Copyright 2025. All Rights Reserved by MedPath